Skip to main content
Erschienen in: European Radiology 8/2020

24.03.2020 | Magnetic Resonance

A clinically feasible 7-Tesla protocol for the identification of cortical lesions in Multiple Sclerosis

verfasst von: Sirio Cocozza, Mirco Cosottini, Alessio Signori, Lazar Fleysher, Mohamed Mounir El Mendili, Fred Lublin, Matilde Inglese, Luca Roccatagliata

Erschienen in: European Radiology | Ausgabe 8/2020

Einloggen, um Zugang zu erhalten

Abstract

Objectives

The aim of this study was to evaluate the capability of sequences acquired on a 7-T MRI scanner, within times and anatomical coverage appropriate for clinical studies, to identify cortical lesions (CLs) in patients with Multiple Sclerosis (MS). Furthermore, we aimed to confirm the clinical significance of CL, testing the correlations between gray matter (GM) lesions and clinical scores.

Methods

A 7-T MRI protocol included 3D-T1-weighted and T2*-weighted sequences. Images were evaluated independently by three readers of different experience, and the number of CLs was recorded. Between-rater concordance was assessed calculating the intraclass correlation coefficient (ICC). Lin’s concordance correlation coefficient was used to compare CL detection between sequences, while partial correlations and multivariable regression models were used to study the relationship between CL and clinical data.

Results

Forty MS patients (M/F, 17/23; 44.7 ± 12.6 years) were enrolled in this study, and CLs were identified in 35/40 subjects (87.5%). CL detection rate on 3D-T1-weighted images was significantly correlated with the detection rate on T2*-weighted images (r = 0.99; p < 0.001), with high concordance between readers (ICC ≥ 0.995). CLs were significantly correlated with both motor and cognitive scores (all with p ≤ 0.04).

Conclusions

CL can be identified over the whole brain at 7-T in MS using a 3D-T1-weighted volume, acquired in a clinically feasible time and with comparable performance to that achievable using the T2*-weighted sequence. Based on the central role of CL in the development of clinical disability, we suggest that 3D-T1-weighted volume may play a role in the evaluation of CL in MS undergoing MRI on ultra-high-field scanners.

Key Points

• Cortical lesions can be identified in a clinically feasible time with a 7-T protocol, which includes a 3D-T1-weighted volume.
• Cortical lesions correlated significantly with both motor and cognitive disability in MS patients.
• Given their correlation with clinical disability, evaluation of a cortical lesion on a 7-T clinical protocol could help in the management of MS patients.
Literatur
1.
Zurück zum Zitat Inglese M, Petracca M (2018) MRI in multiple sclerosis: clinical and research update. Curr Opin Neurol 31:249–255CrossRef Inglese M, Petracca M (2018) MRI in multiple sclerosis: clinical and research update. Curr Opin Neurol 31:249–255CrossRef
2.
Zurück zum Zitat Brownell B, Hughes JT (1962) The distribution of plaques in the cerebrum in multiple sclerosis. J Neurol Neurosurg Psychiatry 25:315–320CrossRef Brownell B, Hughes JT (1962) The distribution of plaques in the cerebrum in multiple sclerosis. J Neurol Neurosurg Psychiatry 25:315–320CrossRef
3.
Zurück zum Zitat Bo L, Vedeler CA, Nyland HI, Trapp BD, Mork SJ (2003) Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J Neuropathol Exp Neurol 62:723–732CrossRef Bo L, Vedeler CA, Nyland HI, Trapp BD, Mork SJ (2003) Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J Neuropathol Exp Neurol 62:723–732CrossRef
4.
Zurück zum Zitat Kidd D, Barkhof F, McConnell R, Algra PR, Allen IV, Revesz T (1999) Cortical lesions in multiple sclerosis. Brain 122(Pt 1):17–26CrossRef Kidd D, Barkhof F, McConnell R, Algra PR, Allen IV, Revesz T (1999) Cortical lesions in multiple sclerosis. Brain 122(Pt 1):17–26CrossRef
5.
Zurück zum Zitat Pirko I, Lucchinetti CF, Sriram S, Bakshi R (2007) Gray matter involvement in multiple sclerosis. Neurology 68:634–642CrossRef Pirko I, Lucchinetti CF, Sriram S, Bakshi R (2007) Gray matter involvement in multiple sclerosis. Neurology 68:634–642CrossRef
6.
Zurück zum Zitat Calabrese M, Filippi M, Gallo P (2010) Cortical lesions in multiple sclerosis. Nat Rev Neurol 6:438–444CrossRef Calabrese M, Filippi M, Gallo P (2010) Cortical lesions in multiple sclerosis. Nat Rev Neurol 6:438–444CrossRef
7.
Zurück zum Zitat Inglese M, Fleysher L, Oesingmann N, Petracca M (2018) Clinical applications of ultra-high field magnetic resonance imaging in multiple sclerosis. Expert Rev Neurother 18:221–230CrossRef Inglese M, Fleysher L, Oesingmann N, Petracca M (2018) Clinical applications of ultra-high field magnetic resonance imaging in multiple sclerosis. Expert Rev Neurother 18:221–230CrossRef
8.
Zurück zum Zitat Maranzano J, Dadar M, Rudko DA et al (2019) Comparison of multiple sclerosis cortical lesion types detected by multicontrast 3T and 7T MRI. AJNR Am J Neuroradiol 40:1162–1169CrossRef Maranzano J, Dadar M, Rudko DA et al (2019) Comparison of multiple sclerosis cortical lesion types detected by multicontrast 3T and 7T MRI. AJNR Am J Neuroradiol 40:1162–1169CrossRef
9.
Zurück zum Zitat Beck ES, Sati P, Sethi V et al (2018) Improved visualization of cortical lesions in multiple sclerosis using 7T MP2RAGE. AJNR Am J Neuroradiol 39:459–466CrossRef Beck ES, Sati P, Sethi V et al (2018) Improved visualization of cortical lesions in multiple sclerosis using 7T MP2RAGE. AJNR Am J Neuroradiol 39:459–466CrossRef
10.
Zurück zum Zitat Cohen-Adad J, Benner T, Greve D et al (2011) In vivo evidence of disseminated subpial T2* signal changes in multiple sclerosis at 7 T: a surface-based analysis. Neuroimage 57:55–62CrossRef Cohen-Adad J, Benner T, Greve D et al (2011) In vivo evidence of disseminated subpial T2* signal changes in multiple sclerosis at 7 T: a surface-based analysis. Neuroimage 57:55–62CrossRef
11.
Zurück zum Zitat Datta R, Sethi V, Ly S et al (2017) 7T MRI visualization of cortical lesions in adolescents and young adults with pediatric-onset multiple sclerosis. J Neuroimaging 27:447–452CrossRef Datta R, Sethi V, Ly S et al (2017) 7T MRI visualization of cortical lesions in adolescents and young adults with pediatric-onset multiple sclerosis. J Neuroimaging 27:447–452CrossRef
12.
Zurück zum Zitat Mainero C, Benner T, Radding A et al (2009) In vivo imaging of cortical pathology in multiple sclerosis using ultra-high field MRI. Neurology 73:941–948CrossRef Mainero C, Benner T, Radding A et al (2009) In vivo imaging of cortical pathology in multiple sclerosis using ultra-high field MRI. Neurology 73:941–948CrossRef
13.
Zurück zum Zitat Mainero C, Louapre C, Govindarajan ST et al (2015) A gradient in cortical pathology in multiple sclerosis by in vivo quantitative 7 T imaging. Brain 138:932–945CrossRef Mainero C, Louapre C, Govindarajan ST et al (2015) A gradient in cortical pathology in multiple sclerosis by in vivo quantitative 7 T imaging. Brain 138:932–945CrossRef
14.
Zurück zum Zitat Treaba CA, Granberg TE, Sormani MP et al (2019) Longitudinal characterization of cortical lesion development and evolution in multiple sclerosis with 7.0-T MRI. Radiology 291:740–749CrossRef Treaba CA, Granberg TE, Sormani MP et al (2019) Longitudinal characterization of cortical lesion development and evolution in multiple sclerosis with 7.0-T MRI. Radiology 291:740–749CrossRef
16.
Zurück zum Zitat Polman CH, Reingold SC, Banwell B et al (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69:292–302CrossRef Polman CH, Reingold SC, Banwell B et al (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69:292–302CrossRef
17.
Zurück zum Zitat Lublin FD, Reingold SC, Cohen JA et al (2014) Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology 83:278–286CrossRef Lublin FD, Reingold SC, Cohen JA et al (2014) Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology 83:278–286CrossRef
18.
Zurück zum Zitat Benedict RH, Amato MP, Boringa J et al (2012) Brief international cognitive assessment for MS (BICAMS): international standards for validation. BMC Neurol 12:55CrossRef Benedict RH, Amato MP, Boringa J et al (2012) Brief international cognitive assessment for MS (BICAMS): international standards for validation. BMC Neurol 12:55CrossRef
19.
Zurück zum Zitat Jenkinson M, Bannister P, Brady M, Smith S (2002) Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage 17:825–841CrossRef Jenkinson M, Bannister P, Brady M, Smith S (2002) Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage 17:825–841CrossRef
20.
Zurück zum Zitat Geurts JJ, Bo L, Pouwels PJ, Castelijns JA, Polman CH, Barkhof F (2005) Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology. AJNR Am J Neuroradiol 26:572–577PubMed Geurts JJ, Bo L, Pouwels PJ, Castelijns JA, Polman CH, Barkhof F (2005) Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology. AJNR Am J Neuroradiol 26:572–577PubMed
21.
Zurück zum Zitat Peterson JW, Bo L, Mork S, Chang A, Trapp BD (2001) Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 50:389–400CrossRef Peterson JW, Bo L, Mork S, Chang A, Trapp BD (2001) Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 50:389–400CrossRef
22.
Zurück zum Zitat Harrison DM, Roy S, Oh J et al (2015) Association of cortical lesion burden on 7-T magnetic resonance imaging with cognition and disability in multiple sclerosis. JAMA Neurol 72:1004–1012CrossRef Harrison DM, Roy S, Oh J et al (2015) Association of cortical lesion burden on 7-T magnetic resonance imaging with cognition and disability in multiple sclerosis. JAMA Neurol 72:1004–1012CrossRef
23.
Zurück zum Zitat Jonkman LE, Fleysher L, Steenwijk MD et al (2016) Ultra-high field MTR and qR2* differentiates subpial cortical lesions from normal-appearing gray matter in multiple sclerosis. Mult Scler 22:1306–1314CrossRef Jonkman LE, Fleysher L, Steenwijk MD et al (2016) Ultra-high field MTR and qR2* differentiates subpial cortical lesions from normal-appearing gray matter in multiple sclerosis. Mult Scler 22:1306–1314CrossRef
24.
Zurück zum Zitat Jonkman LE, Klaver R, Fleysher L, Inglese M, Geurts JJ (2015) Ultra-high-field MRI visualization of cortical multiple sclerosis lesions with T2 and T2*: a postmortem MRI and histopathology study. AJNR Am J Neuroradiol 36:2062–2067CrossRef Jonkman LE, Klaver R, Fleysher L, Inglese M, Geurts JJ (2015) Ultra-high-field MRI visualization of cortical multiple sclerosis lesions with T2 and T2*: a postmortem MRI and histopathology study. AJNR Am J Neuroradiol 36:2062–2067CrossRef
25.
Zurück zum Zitat Kollia K, Maderwald S, Putzki N et al (2009) First clinical study on ultra-high-field MR imaging in patients with multiple sclerosis: comparison of 1.5T and 7T. AJNR Am J Neuroradiol 30:699–702CrossRef Kollia K, Maderwald S, Putzki N et al (2009) First clinical study on ultra-high-field MR imaging in patients with multiple sclerosis: comparison of 1.5T and 7T. AJNR Am J Neuroradiol 30:699–702CrossRef
26.
Zurück zum Zitat Nielsen AS, Kinkel RP, Madigan N, Tinelli E, Benner T, Mainero C (2013) Contribution of cortical lesion subtypes at 7T MRI to physical and cognitive performance in MS. Neurology 81:641–649CrossRef Nielsen AS, Kinkel RP, Madigan N, Tinelli E, Benner T, Mainero C (2013) Contribution of cortical lesion subtypes at 7T MRI to physical and cognitive performance in MS. Neurology 81:641–649CrossRef
27.
Zurück zum Zitat Pitt D, Boster A, Pei W et al (2010) Imaging cortical lesions in multiple sclerosis with ultra-high-field magnetic resonance imaging. Arch Neurol 67:812–818CrossRef Pitt D, Boster A, Pei W et al (2010) Imaging cortical lesions in multiple sclerosis with ultra-high-field magnetic resonance imaging. Arch Neurol 67:812–818CrossRef
28.
Zurück zum Zitat Kilsdonk ID, Jonkman LE, Klaver R et al (2016) Increased cortical grey matter lesion detection in multiple sclerosis with 7 T MRI: a post-mortem verification study. Brain 139:1472–1481CrossRef Kilsdonk ID, Jonkman LE, Klaver R et al (2016) Increased cortical grey matter lesion detection in multiple sclerosis with 7 T MRI: a post-mortem verification study. Brain 139:1472–1481CrossRef
29.
Zurück zum Zitat Calabrese M, Agosta F, Rinaldi F et al (2009) Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. Arch Neurol 66:1144–1150CrossRef Calabrese M, Agosta F, Rinaldi F et al (2009) Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. Arch Neurol 66:1144–1150CrossRef
30.
Zurück zum Zitat Calabrese M, Rocca MA, Atzori M et al (2010) A 3-year magnetic resonance imaging study of cortical lesions in relapse-onset multiple sclerosis. Ann Neurol 67:376–383PubMed Calabrese M, Rocca MA, Atzori M et al (2010) A 3-year magnetic resonance imaging study of cortical lesions in relapse-onset multiple sclerosis. Ann Neurol 67:376–383PubMed
31.
Zurück zum Zitat Curti E, Graziuso S, Tsantes E, Crisi G, Granella F (2018) Correlation between cortical lesions and cognitive impairment in multiple sclerosis. Brain Behav 8:e00955CrossRef Curti E, Graziuso S, Tsantes E, Crisi G, Granella F (2018) Correlation between cortical lesions and cognitive impairment in multiple sclerosis. Brain Behav 8:e00955CrossRef
32.
Zurück zum Zitat Damasceno A, Damasceno BP, Cendes F (2014) The clinical impact of cerebellar grey matter pathology in multiple sclerosis. PLoS One 9(5):e96193 Damasceno A, Damasceno BP, Cendes F (2014) The clinical impact of cerebellar grey matter pathology in multiple sclerosis. PLoS One 9(5):e96193
33.
Zurück zum Zitat van de Pavert SHP, Muhlert N, Sethi V et al (2016) DIR-visible grey matter lesions and atrophy in multiple sclerosis: partners in crime? J Neurol Neurosurg Psychiatry 87:461–467 van de Pavert SHP, Muhlert N, Sethi V et al (2016) DIR-visible grey matter lesions and atrophy in multiple sclerosis: partners in crime? J Neurol Neurosurg Psychiatry 87:461–467
34.
Zurück zum Zitat Nielsen AS, Kinkel RP, Tinelli E, Benner T, Cohen-Adad J, Mainero C (2012) Focal cortical lesion detection in multiple sclerosis: 3 tesla DIR versus 7 tesla FLASH-T2. J Magn Reson Imaging 35:537–542CrossRef Nielsen AS, Kinkel RP, Tinelli E, Benner T, Cohen-Adad J, Mainero C (2012) Focal cortical lesion detection in multiple sclerosis: 3 tesla DIR versus 7 tesla FLASH-T2. J Magn Reson Imaging 35:537–542CrossRef
Metadaten
Titel
A clinically feasible 7-Tesla protocol for the identification of cortical lesions in Multiple Sclerosis
verfasst von
Sirio Cocozza
Mirco Cosottini
Alessio Signori
Lazar Fleysher
Mohamed Mounir El Mendili
Fred Lublin
Matilde Inglese
Luca Roccatagliata
Publikationsdatum
24.03.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 8/2020
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-020-06803-y

Weitere Artikel der Ausgabe 8/2020

European Radiology 8/2020 Zur Ausgabe

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.